Brief: Meridian Bioscience Inc Reports Q3 Net Loss Per Basic Common Share Of $0.17

VivoPower

05/08/2022 13:22

Aug 5 (Reuters) - Meridian Bioscience Inc  VIVO.O :
    * MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022
OPERATING
RESULTS
    * Q3 REVENUE ROSE 7 PERCENT TO $67.8 MILLION
    * AT JUNE 30, 2022, CASH AND CASH EQUIVALENTS WERE $83.5
MILLION
    * QTRLY NET LOSS PER BASIC COMMON SHARE $0.17

Source text for Eikon:  ID:nPn980wBXa 
Further company coverage:  VIVO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))